May Mabro
Impact in
- Oncology top 2%
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
- Colorectal Cancer Surgical Treatments
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Oncology 41
- Colorectal Cancer Treatments and Studies 34
- Cancer Treatment and Pharmacology 18
-
- Gastric Cancer Management and Outcomes 13
- Lung Cancer Treatments and Mutations 9
- Brain Metastases and Treatment 4
- Co-authors
- Thierry André (39 shared papers)Aimery de Gramont (33 shared papers)Christophe Louvet (34 shared papers)Élisabeth Carola (12 shared papers)Pascal Artru (15 shared papers)Christophe Tournigand (18 shared papers)M Krulik (9 shared papers)Gérard Lledo (15 shared papers)
In The Last Decade
May Mabro
54 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 76
- Oncology 1.1k
- Hepatology 253
- Cancer Research 171
- Pulmonary and Respiratory Medicine 314
- Pathology and Forensic Medicine 162
Countries citing papers authored by May Mabro
This map shows the geographic impact of May Mabro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by May Mabro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites May Mabro more than expected).
Fields of papers citing papers by May Mabro
This network shows the impact of papers produced by May Mabro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by May Mabro. The network helps show where May Mabro may publish in the future.
Co-authors
The 25 scholars most cited alongside May Mabro, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 54 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 264 | |
| 2 | 1999 | 223 | |
| 3 | 2001 | 114 | |
| 4 | 2000 | 101 | |
| 5 | 2009 | 78 | |
| 6 | 2021 | 73 | |
| 7 | 2004 | 70 | |
| 8 | 2012 | 70 | |
| 9 | 2007 | 69 | |
| 10 | 2019 | 48 | |
| 11 | 2006 | 38 | |
| 12 | 2006 | 35 | |
| 13 | 2009 | 32 | |
| 14 | 1999 | 31 | |
| 15 | 2012 | 29 | |
| 16 | 2003 | 27 | |
| 17 | 2006 | 24 | |
| 18 | 2019 | 21 | |
| 19 | 2003 | 19 | |
| 20 | 2023 | 17 |
About May Mabro
May Mabro is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Hepatology, Surgery and Molecular Biology, having authored 54 papers that have together received 1.5k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (34 papers), Cancer Treatment and Pharmacology (18 papers), Gastric Cancer Management and Outcomes (13 papers), Lung Cancer Treatments and Mutations (9 papers), Hepatocellular Carcinoma Treatment and Prognosis (8 papers), Brain Metastases and Treatment (4 papers), Cancer Genomics and Diagnostics (3 papers) and Inflammatory mediators and NSAID effects (3 papers). The work is most often cited by research in Oncology (1.1k citations), Hepatology (253 citations), Cancer Research (171 citations), Pulmonary and Respiratory Medicine (314 citations) and Pathology and Forensic Medicine (162 citations). May Mabro has collaborated with scholars based in France, Austria and Canada. Frequent co-authors include Thierry André, Aimery de Gramont, Christophe Louvet, Élisabeth Carola, Pascal Artru, Christophe Tournigand, M Krulik, Gérard Lledo, Benoist Chibaudel and Laurent Mineur. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, European Journal of Cancer, Cancer Investigation and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.